SSAA09E1 | B2722

SSAA09E1 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry.

SSAA09E1 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry.

B2722 | SSAA09E1 DataSheet

Alternate Name/Synonyms: [(Z)-1-Thiophen-2-ylethylideneamino]thiourea

Appearance: Crystalline solid

Formulation:

CAS Number: 433212-75-0

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₇H₉N₃S₂

Molecular Weight: 199.3

Cell-Permeable?: TRUE

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A novel inhibitor of SARS-CoV replication

MDL Number:

PubChem CID:

SMILES: NC(=S)N\N=C(\C)c1cccs1

InChi: AuxInfo=1/1/N:7,1,3,2,6,5,10,12,8,9,11,4/rA:12CCCSCCCNNCSN/rB:d1;s1;s2;d3s4;s5;s6;d6;s8;s9;d10;s10;/rC:0,-628,0;196,-716,0;22,-415,0;340,-556,0;233,-370,0;320,-174,0;194,0,0;534,-151,0;660,-325,0;874,-303,0;1000,-477,0;961,-106,0;

InChi Key: PJVHAJJEMJNPHN-UITAMQMPSA-N